News & Updates
Filter by Specialty:
Eosinophil levels do not influence outcomes with triple combo asthma inhaler
Treatment with fixed-dose asthma inhaler combination of mometasone/indacaterol/glycopyrronium (MF/IND/GLY) helps improve lung function and reduce exacerbations as compared with MF/IND and fluticasone/salmeterol (FLU/SAL), regardless of baseline eosinophil levels, according to a post hoc analysis of the IRIDIUM study.
Eosinophil levels do not influence outcomes with triple combo asthma inhaler
07 Jul 2023
Virtual ward feasible home-based care strategy for high-risk COVID-19 patients
A technology-enabled virtual ward may be a feasible alternative to hospitalization for high-risk COVID-19 patients such as the elderly and the immunocompromised, a retrospective cohort study from Singapore suggests.
Virtual ward feasible home-based care strategy for high-risk COVID-19 patients
07 Jul 2023
Add-on fluvoxamine of no benefit in mild-to-moderate COVID-19
In the treatment of patients with mild-to-moderate COVID-19, adding fluvoxamine to favipiravir does not appear to prevent disease progression or improve certain outcomes, according to the results of an open-label study.
Add-on fluvoxamine of no benefit in mild-to-moderate COVID-19
07 Jul 2023
COVID outcomes worse in polluted cities
More evidence suggests that people exposed to more air pollution during the pandemic are at greater risk for COVID-19 infection, hospitalization, and death, but the exact mechanism behind the link is unknown.
